Relay Therapeutics
Prior to joining Relay, Imogen Pryce worked in corporate strategy at Shire Pharmaceuticals. There, she managed and contributed to multiple projects ranging from whole company initiatives to targeted efforts within specific therapeutic areas and functions.
Prior to joining Shire, Imogen worked at the Boston Consulting Group, where she was a core member of the health care practice area. She advised senior client teams on a number of topics, including corporate strategy, M&A due diligence and R&D portfolio prioritization.
Imogen holds a Ph.D. in chemical engineering from the California Institute of Technology and a B.S. from the Ohio State University.
Relay Therapeutics
1 followers
Relay Therapeutics is a clinical-stage precision medicines company transforming the drug discovery process. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, our approach combines unprecedented computational power with leading-edge experimental approaches across the fields of structural biology, biophysics, chemistry and biology.